Gladius Capital Management’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Gladius Capital Management’s Portfolio TARO Stock Details TARO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-761	Closed	-$32.7K	–	363
2024 Q2	$32.7K	Sell	761 -45	-6%	-$1.91K	﹤0.01%	210
2024 Q1	$34.1K	Sell	806 -76	-9%	-$3.2K	0.01%	275
2023 Q4	$36.9K	Buy	882 +76	+9%	+$2.8K	0.01%	230
2023 Q3	$30.4K	Buy	806 +94	+13%	+$3.53K	﹤0.01%	298
2023 Q2	$27K	Buy	+712	New	+$22.4K	﹤0.01%	274

Other funds holding TARO

MPWT

MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return

Gladius Capital Management's TARO Position: Q3 2024 in Review

Gladius Capital Management sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q3 2024, closing a stake of 761 shares — an estimated $32.7K sold.

Gladius Capital Management first reported a position in TARO in Q2 2023 and held it in 5 quarters. The position peaked at $36.9K in Q4 2023. 6 funds tracked by Wall St. Rank hold TARO as of Q3 2024.

Gladius Capital Management reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q3 2024 after selling out during the quarter.
Gladius Capital Management sold 761 Taro Pharmaceutical Industries Ltd. shares in Q3 2024, an estimated $32.7K.
Gladius Capital Management first reported a position in Taro Pharmaceutical Industries Ltd. in Q2 2023 and held it in 5 quarters.
Gladius Capital Management's Taro Pharmaceutical Industries Ltd. position peaked at $36.9K in Q4 2023.
6 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q3 2024.

Based on Gladius Capital Management's 13F filing for Q3 2024, filed 6 Nov 2024.